» Articles » PMID: 16382020

Panel of Reactive T Cells As a Measurement of Primed Cellular Alloimmunity in Kidney Transplant Candidates

Overview
Specialty Nephrology
Date 2005 Dec 31
PMID 16382020
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Pretransplantation panel reactive antibody (PRA) testing assesses posttransplantation risk for antibody-mediated graft injury. It was postulated analogously that screening for effector/memory alloreactive T cells by "panel of reactive T cells" (PRT) using IFN-gamma enzyme-linked immunosorbent spot assays would evaluate independently cellular alloimmunity in transplant candidates. Peripheral blood lymphocytes from 41 hemodialysis patients who were awaiting first renal transplants were tested against a panel of allogeneic stimulator cells. Positive assays were defined arbitrarily as >25 spots/300,000 peripheral blood lymphocytes, and positive PRT was defined as when the responder reacted to 40 or 75% (PRT-75) of the stimulators. Seventeen percent of patients were PRT-75+, whereas 32% were PRA+. Twelve percent of the cohort was PRT-75+/PRA-, and only 5% of the patients were PRA+/PRT-75+, indicating that T cell alloreactivity did not routinely imply B cell sensitization and vice versa. PRT-75+ patients were more likely to be younger (<55 yr) and black. In contrast, a positive PRA was significantly associated with female gender but not race or age. Pretransplantation screening of cellular alloimmunity by enzyme-linked immunosorbent spot-based PRT detects a subset of hemodialysis patients who differ from those that are PRA+. Preliminary correlations with posttransplantation outcome in seven recipients suggest that PRT screening has the potential to aid in risk assessment in renal transplant candidates.

Citing Articles

Pretransplant, Th17 dominant alloreactivity in highly sensitized kidney transplant candidates.

Negi S, Rutman A, Saw C, Paraskevas S, Tchervenkov J Front Transplant. 2024; 3:1336563.

PMID: 38993777 PMC: 11235243. DOI: 10.3389/frtra.2024.1336563.


p40 homodimers bridge ischemic tissue inflammation and heterologous alloimmunity in mice via IL-15 transpresentation.

Tsuda H, Keslar K, Baldwin 3rd W, Heeger P, Valujskikh A, Fairchild R J Clin Invest. 2024; 134(6).

PMID: 38271093 PMC: 10940089. DOI: 10.1172/JCI172760.


Recipient APOL1 risk alleles associate with death-censored renal allograft survival and rejection episodes.

Zhang Z, Sun Z, Fu J, Lin Q, Banu K, Chauhan K J Clin Invest. 2021; 131(22).

PMID: 34499625 PMC: 8592534. DOI: 10.1172/JCI146643.


Endogenous memory T cells with donor-reactivity: early post-transplant mediators of acute graft injury in unsensitized recipients.

Koritzinsky E, Tsuda H, Fairchild R Transpl Int. 2021; 34(8):1360-1373.

PMID: 33963616 PMC: 8389524. DOI: 10.1111/tri.13900.


Pre-existing Alloreactive T and B Cells and Their Possible Relevance for Pre-transplant Risk Estimation in Kidney Transplant Recipients.

Karahan G, Claas F, Heidt S Front Med (Lausanne). 2020; 7:340.

PMID: 32793610 PMC: 7385137. DOI: 10.3389/fmed.2020.00340.